RxDoctor Payments Data

William Garrett, MD

Family Medicine · Elizabethton, TNNPI 1649376765

Payments from drug & device makers

$1,283in general payments, 2019–2025

Across 79 payments — averaging $16.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$385
  • AstraZeneca$312
  • AbbVie$113
  • Takeda Pharmaceuticals U.S.A., Inc.$72
  • Boehringer Ingelheim$61
  • Novo Nordisk$57
  • plus $283 from 11 others

What the payments were for

  • Food & beverage$1,283100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,283 in reported general payments places this provider in the 60th percentile of 2,087 family medicine providers in Tennessee.

See all family medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$39,715
Medicare patients
76
Services billed
1,207

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban53$50,432
OzempicSemaglutide18$24,414
NexiumEsomeprazole Magnesium23$17,728
Breztri AerosphereBudesonide/Glycopyr/Formoterol21$17,221
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog18$13,273
UbrelvyUbrogepant11$12,194
SymbicortBudesonide/Formoterol Fumarate30$12,134
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$12,116
TrulicityDulaglutide13$11,891
LinzessLinaclotide15$9,380
PremproEstrogen,con/M-Progest Acet14$5,446
LantusInsulin Glargine,hum.Rec.Anlog41$5,063
Lantus SolostarInsulin Glargine,hum.Rec.Anlog31$4,288
Famotidine169$4,254
Albuterol Sulfate HfaAlbuterol Sulfate96$3,985

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Prempro$27$55,87867 claims
AstraZenecaNexium, Breztri Aerosphere, Symbicort$312$47,08374 claims
Novo NordiskOzempic$57$24,41418 claims
AbbVieUbrelvy, Linzess, Synthroid$113$24,01752 claims
GSKTrelegy Ellipta$385$12,11611 claims
Lilly USA, LLCTrulicity$22$11,89113 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 2,087 family medicine providers in Tennessee.

Other family medicine in Elizabethton

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →